| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMJCARD.2008.04.060 |
| P698 | PubMed publication ID | 18774000 |
| P50 | author | Wolfgang Dichtl | Q41833071 |
| P2093 | author name string | Thomas Bartel | |
| Silvana Müller | |||
| Florian Hintringer | |||
| Otmar Pachinger | |||
| Hanno Ulmer | |||
| Wilhelm Grander | |||
| Markus Reinthaler | |||
| Gudrun Maria Feuchtner | |||
| Hannes Franz Alber | |||
| Alois Süssenbacher | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stenosis | Q2343082 |
| P304 | page(s) | 743-748 | |
| P577 | publication date | 2008-07-02 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). | |
| P478 | volume | 102 |
| Q48156144 | Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts |
| Q59811179 | Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis |
| Q55053453 | Bicuspid Aortic Valve Stenosis and the Effect of Vitamin K2 on Calcification Using 18F-Sodium Fluoride Positron Emission Tomography/Magnetic Resonance: The BASIK2 Rationale and Trial Design. |
| Q50420240 | Calcific Aortic Valve Disease: a Developmental Biology Perspective |
| Q64251798 | Clinical, sonographic characteristics and long-term prognosis of valvular heart disease in elderly patients |
| Q30435363 | Current management of calcific aortic stenosis |
| Q92343929 | Development of calcific aortic valve disease: Do we know enough for new clinical trials? |
| Q53469225 | Effects of oxidized low density lipoprotein on transformation of valvular myofibroblasts to osteoblast-like phenotype. |
| Q34378569 | Evidence for Active Regulation of Pro-Osteogenic Signaling in Advanced Aortic Valve Disease |
| Q35065597 | High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy |
| Q46162925 | Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis |
| Q41608259 | Is there evidence for statins in the treatment of aortic valve stenosis? |
| Q46259874 | Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis |
| Q38839978 | Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis |
| Q57829811 | Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men |
| Q46229988 | Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study |
| Q89794403 | Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study |
| Q43199667 | Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis |
| Q38946280 | Statins for aortic valve stenosis. |
| Q37857729 | Statins for progression of aortic valve stenosis and the best evidence for making decisions in health care. |
| Q31058337 | The effect of statins therapy in aortic stenosis: Meta-analysis comparison data of RCTs and observationals |
Search more.